The Journal of pediatrics · 2026
Characterizing Barriers to Living Donor Liver Transplantation for Pediatric Recipients: Qualitative Results from the SOCIAL-Tx Study.
СтатьяМногоцентровое исследованиеНаблюдательное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kelly Morgan, Ali Saba, Huerta Andrea, Hsu Evelyn K, Squires James E, Campbell Kathleen M, Gupta Nitika A, Zielsdorf Shannon M, Ebel Noelle H, Bucuvalas John C, Lai Jennifer C, Wadhwani Sharad I
Аннотация
OBJECTIVE: To characterize barriers and facilitators influencing caregiver decision-making regarding living donor liver transplantation (LDLT) for children with end-stage liver disease.
STUDY DESIGN: This qualitative study used semistructured, in-depth interviews conducted between May 2023 and March 2025 with caregivers of pediatric liver transplant recipients enrolled in the Social & Contextual Impact on Children Undergoing Liver Transplantation study cohort. Interviews were recorded and professionally transcribed, then independently coded by 3 reviewers using a codebook informed by the capability, opportunity, motivation - behavior model, an implementation science framework. Codes were compared and reconciled to generate themes.
RESULTS: Eighteen caregivers participated; 50% reported household incomes <150% of the federal poverty level. Seven themes emerged: (1) insufficient time to comprehend transplant options, (2) perceived or actual lack of eligible donors in caregiver's social network, (3) concern about donor health consequences, (4) challenge of being both a caregiver and donor, (5) discordance between discomfort asking others to donate and response received, (6) limited knowledge about differences between whole and split liver, and (7) the appeal of flexible surgical scheduling offered by LDLT. These themes highlight the interplay between cognitive, social, and practical factors influencing pursuit of living donation.
CONCLUSIONS: Strategies to support decision-making about LDLT should include counseling about the procedure's benefits early in the transplant evaluation process, helping identify nondirected donors and reducing the caregiving burden during the donor recovery period. Such efforts should prioritize under-resourced families to enhance equitable outcomes for children with end-stage liver disease.
CLINICAL TRIAL REGISTRATION: www.
CLINICALTRIALS: gov NCT04551742.
STUDY DESIGN: This qualitative study used semistructured, in-depth interviews conducted between May 2023 and March 2025 with caregivers of pediatric liver transplant recipients enrolled in the Social & Contextual Impact on Children Undergoing Liver Transplantation study cohort. Interviews were recorded and professionally transcribed, then independently coded by 3 reviewers using a codebook informed by the capability, opportunity, motivation - behavior model, an implementation science framework. Codes were compared and reconciled to generate themes.
RESULTS: Eighteen caregivers participated; 50% reported household incomes <150% of the federal poverty level. Seven themes emerged: (1) insufficient time to comprehend transplant options, (2) perceived or actual lack of eligible donors in caregiver's social network, (3) concern about donor health consequences, (4) challenge of being both a caregiver and donor, (5) discordance between discomfort asking others to donate and response received, (6) limited knowledge about differences between whole and split liver, and (7) the appeal of flexible surgical scheduling offered by LDLT. These themes highlight the interplay between cognitive, social, and practical factors influencing pursuit of living donation.
CONCLUSIONS: Strategies to support decision-making about LDLT should include counseling about the procedure's benefits early in the transplant evaluation process, helping identify nondirected donors and reducing the caregiving burden during the donor recovery period. Such efforts should prioritize under-resourced families to enhance equitable outcomes for children with end-stage liver disease.
CLINICAL TRIAL REGISTRATION: www.
CLINICALTRIALS: gov NCT04551742.